Cargando…
Erratum to: Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer
Autores principales: | Wang, Bi-Yun, Zhang, Jian, Wang, Jia-Lei, Sun, Si, Wang, Zhong-Hua, Wang, Lei-Ping, Zhang, Qun-Ling, Lv, Fang-Fang, Cao, En-Ying, Shao, Zhi-Min, Fais, Stefano, Hu, Xi-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589907/ https://www.ncbi.nlm.nih.gov/pubmed/26427752 http://dx.doi.org/10.1186/s13046-015-0220-z |
Ejemplares similares
-
Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer
por: Wang, Bi-Yun, et al.
Publicado: (2015) -
Erratum to: Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility
por: Seto, Charlie T., et al.
Publicado: (2016) -
Erratum: Efficacy of Proton Pump Inhibitors for Patients with Duodenal Ulcers: A Pairwise and Network Meta-analysis of Randomized Controlled Trials
Publicado: (2017) -
Erratum to: Outcome of maintenance systemic chemotherapy with drug-free interval for metastatic urothelial carcinoma
por: Abe, T, et al.
Publicado: (2020) -
Erratum: Prognostic impact of local radiotherapy on metastatic urothelial carcinoma patients receiving systemic chemotherapy
por: Abe, Takashige, et al.
Publicado: (2020)